iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

GPT Healthcare IPO Subscription: Allotment on Feb 27, Listing on Feb 29

19 Mar 2024 , 10:33 AM

GPT Healthcare Ltd's IPO began on February 22 with a price band of ₹177-186 per share. The IPO subscription window closes on February 26, 2024. Click here to subscribe the IPO.

At the time of writing on the first day, the Retail subscription is at 0.57 times, and the non-institutional quota records 0.12 times subscription. The QIB is subscribed at 0.00 times. Allotment is scheduled for February 27, and listing on NSE and BSE is set for February 29, 2024.

GPT Healthcare collected ₹157.54 Crore from anchor investors a day before the IPO. The IPO includes a fresh issue of ₹40 Crore and an OFS of up to 2.6 Crore equity shares by BanyanTree Growth Capital II.

Funds from the fresh issue (₹30 Crore) will be used for debt payment and general corporate purposes. The IPO is expected to mobilize ₹501.67 Crore at the lower price band and ₹525.14 Crore at the upper end.

GPT Healthcare, operating under ILS Hospitals, started in 2000 and currently manages four multi-specialty hospitals with 561 beds.

It competes with listed peers such as Global Health Ltd, Krishna Institute of Medical Sciences Ltd, Jupiter Life Line Hospitals Ltd, Yatharth Hospital & Trauma Care Services Ltd, and Shalby Ltd.

The IPO allocations include 50% for qualified institutional buyers, 35% for non-institutional investors, and 15% for retail investors.

Investors can bid for a minimum of 80 equity shares and in multiples of 80 thereafter. Financially, GPT Healthcare reported a 7.3% increase in total income, reaching ₹361.03 Crore in FY23 from ₹337.41 Crore in FY22.

JM Financial is the sole book-running lead manager for the IPO, and the equity shares are proposed to be listed on both the BSE and the NSE.

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • BSE
  • GPT Healthcare
  • IPO subscription
  • news
  • NSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
15 Apr 2024   |   12:16 PM
Images
15 Apr 2024   |   10:33 AM
Images
15 Apr 2024   |   09:44 AM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

closeIcon

Get better recommendations & make better investments

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp